ASSESSING THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY COMPETITIVE ADVANTAGE. 

Abstract:

With the rapid advancement of financial technology (fintech), various industries, including the pharmaceutical sector, have witnessed significant transformations in recent years. This study aims to assess the impact of fintech on the competitive advantage of pharmaceutical companies. Fintech refers to the application of innovative technologies in financial services, such as mobile payments, blockchain, artificial intelligence, and big data analytics. These technologies have the potential to disrupt traditional business models, enhance operational efficiency, and create new opportunities in the pharmaceutical industry.

This research utilizes a mixed-methods approach, combining quantitative analysis and qualitative insights gathered through interviews and case studies. The quantitative analysis involves examining financial indicators, such as profitability, liquidity, and return on investment, of pharmaceutical companies that have adopted fintech solutions compared to those who have not. Additionally, data from secondary sources, including financial reports and industry databases, will be collected and analyzed.

The qualitative aspect of this study involves conducting interviews with key stakeholders in pharmaceutical companies and fintech providers. These interviews will provide valuable insights into the challenges, opportunities, and strategies associated with the adoption of fintech in the pharmaceutical industry. Furthermore, case studies of pharmaceutical companies that have successfully leveraged fintech will be conducted to identify best practices and lessons learned.

The findings of this study will contribute to the existing literature on the intersection of fintech and pharmaceuticals, shedding light on the impact of fintech on the competitive advantage of pharmaceutical companies. It is expected that the adoption of fintech solutions will enable pharmaceutical companies to streamline their financial processes, reduce costs, improve supply chain management, enhance customer experiences, and accelerate innovation. These advantages can translate into improved market positioning, increased market share, and enhanced competitiveness in the pharmaceutical industry.

The implications of this research extend to pharmaceutical executives, policymakers, and researchers, providing them with valuable insights into the potential benefits and challenges associated with fintech adoption. By understanding the impact of fintech on competitive advantage, pharmaceutical companies can make informed decisions regarding the integration of fintech solutions into their operations and develop strategies to stay ahead in a rapidly evolving industry.

Keywords: fintech, pharmaceutical industry, competitive advantage, financial technology, innovation, digital transformation

ASSESSING THE IMPACT OF FINTECH ON PHARMACEUTICAL COMPANY COMPETITIVE ADVANTAGE.GET MORE MASTERS COMPUTER SCIENCE

Sharing is caring!